Heightened Expression of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-δ in Human Endometrial Adenocarcinoma
Open Access
- 1 January 2000
- Vol. 2 (6) , 483-490
- https://doi.org/10.1038/sj.neo.7900119
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effects of Tamoxifen on Steroid Hormone Receptors and Hormone Concentration and the Results of DNA Analysis by Flow Cytometry in Endometrial CarcinomaGynecologic Oncology, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2AGenes & Development, 1997
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Clinical aspects of risk in women with endometrial carcinomaJournal of Cellular Biochemistry, 1995
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloningBiochemistry, 1987
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Estrogen use — Risk of endometrial carcinomaGynecologic Oncology, 1978